scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...990978B |
P356 | DOI | 10.1371/JOURNAL.PONE.0090978 |
P932 | PMC publication ID | 3953205 |
P698 | PubMed publication ID | 24626096 |
P5875 | ResearchGate publication ID | 262047043 |
P50 | author | André Cabié | Q37367397 |
Jens Lundgren | Q42325404 | ||
Pablo C Okhuysen | Q54425139 | ||
Lars Østergaard | Q55232366 | ||
Andrew N Phillips | Q87677848 | ||
P2093 | author name string | Marcelo H Losso | |
Ian Williams | |||
Jason V Baker | |||
Gustavo Lopardo | |||
Hartwig Klinker | |||
INSIGHT SMART Study Group | |||
Jemma L O'Connor | |||
Michael J Vjecha | |||
ESPRIT Study Group | |||
Alvaro H Borges | |||
SILCAAT Scientific Committee | |||
P2860 | cites work | Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons | Q39552122 |
Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency | Q44271055 | ||
Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study | Q45061360 | ||
Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study | Q45389079 | ||
Common genetic variants associated with plasma fibrin D-dimer concentration in older European- and African-American adults | Q46385065 | ||
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | Q47853584 | ||
Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. | Q55066043 | ||
Plasma D dimer: a useful marker of fibrin breakdown in renal failure | Q69763956 | ||
Fibrin Degeneration Product Concentrations (D-Dimers) in the Course of Ageing | Q71846271 | ||
Interleukin-6 stimulates coagulation, not fibrinolysis, in humans | Q71848987 | ||
Determinants of fibrin D-dimer in the Edinburgh Artery Study | Q71938771 | ||
Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro | Q72490514 | ||
D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients | Q77924427 | ||
D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderly | Q80417129 | ||
Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism | Q24633827 | ||
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease | Q28731034 | ||
Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
CD4+ count-guided interruption of antiretroviral treatment | Q29619489 | ||
High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection | Q33556997 | ||
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation | Q33597485 | ||
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. | Q33649753 | ||
African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension | Q33804131 | ||
Interleukin-2 therapy in patients with HIV infection | Q33847543 | ||
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection | Q33857515 | ||
Interleukin-6 and d-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection | Q34142791 | ||
Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality | Q34175921 | ||
Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection | Q34423991 | ||
Female hormones and thrombosis | Q34521926 | ||
Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. | Q34796153 | ||
Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study | Q35156330 | ||
HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation | Q36383621 | ||
Endothelial and antithrombotic actions of HDL. | Q36500929 | ||
Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study | Q37144916 | ||
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis | Q37220866 | ||
HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation | Q37310421 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e90978 | |
P577 | publication date | 2014-03-13 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Factors associated with D-dimer levels in HIV-infected individuals | |
P478 | volume | 9 |
Q26768632 | Barriers to a cure for HIV in women |
Q92081837 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |
Q41751842 | Cardiovascular disease associated with the human immunodeficiency virus: an update |
Q97567577 | Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya |
Q35992200 | D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events |
Q45049681 | D-Dimer as a prognostic marker of morbidity and mortality among HIV patients: a call for attention. |
Q35408098 | Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics |
Q36220304 | Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV. |
Q36139186 | Factors Associated With Plasma IL-6 Levels During HIV Infection |
Q38659387 | HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer |
Q52613761 | HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy |
Q42199709 | Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. |
Q98568865 | Impact of COVID-19 on monitoring of therapeutic unfractionated heparin |
Q41454338 | Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity |
Q41989633 | Inflammation Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It? |
Q40692524 | Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection |
Q92249650 | Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis |
Q47190713 | Racial Comparison of D-dimer Levels in U.S. Male Military Personnel Before and After HIV Infection and Viral Suppression |
Q34870233 | Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review |
Q41217657 | Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study |
Q57276037 | Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study |
Search more.